Jeff Scherer
Managing Director
Get their honest, personalized take on your startup.
Sign in to pitch Jeff →At a glance
- Full Name
- Jeff Scherer
- Title
- Managing Director; Co-Head, North America Private Equity Portfolio Group
- Firm
- Bain Capital (Bain Capital Private Equity)
- Firm Type
- Private equity / alternative asset manager (the stub's "Angel Investors" label appears to derive from aggregator profiles describing his personal/early-stage activity, not his Bain role)
- Investment Stage
- Late-stage / buyout and portfolio operations at Bain; aggregator profiles also list Seed / Series A / Series B for personal angel-style activity
- Check Size
- Aggregator-reported personal range $100K–$5.0M, "sweet spot" ~$1.5M (NFX Signal); not an official Bain figure
- Sector Focus
- Industrial; Technology, Media & Telecommunications (TMT); retail/consumer; aggregators also cite FinTech
- Geographic Focus
- North America (Boston/New England), with prior work based in London
- Location
- Boston, Massachusetts (has also been based in London)
Background
Jeff Scherer is a Managing Director at Bain Capital Private Equity, which he joined in 2006. He co-heads the firm's North America Private Equity Portfolio Group — the team responsible for working with management of portfolio companies to drive operational performance and value creation after an investment is made. His investing and portfolio work has centered primarily on the Industrial and the Technology, Media & Telecommunications (TMT) verticals, and he has worked out of both Bain Capital's Boston and London offices over his tenure.
A distinctive feature of his career is his willingness to step directly into operating roles at portfolio companies. According to Bain Capital Private Equity's own profile, he has served in a number of interim executive capacities, including at Brakes Foodservice (the UK foodservice distributor) and at ATW. This operator-style involvement is consistent with his leadership of the Portfolio Group, where the mandate is hands-on company building rather than purely financial sponsorship — reflected in his LinkedIn title referencing a "Head of Operating" function.
Before Bain Capital, Scherer was a consultant at McKinsey & Company, where he advised clients across the technology, industrial, and retail sectors. He holds an MBA from Harvard Business School and a Bachelor of Arts from Davidson College.
A note on identity: several public databases (NFX Signal, RocketReach, Scoutraise, AngelMatch) blend his record with details that more likely belong to other individuals named Jeff/Jeffrey Scherer (for example, an "EVP Merchandising at Michaels Stores" entry and a "Founder/CEO of The Boston Calendar/Joyraft" entry, and a separate Jeffrey Scherer at Cove Hill Partners). The facts above are drawn from Bain Capital's primary bio; the aggregator-only items are flagged where they appear.
Investment Thesis & Focus
- Core mandate at Bain: value creation through portfolio operations — partnering with management teams of acquired companies to improve performance, rather than sourcing seed deals. Sector emphasis on Industrial and TMT.
- Operator-led approach: comfortable taking interim executive roles inside portfolio companies (e.g., Brakes Foodservice, ATW), signaling a hands-on, operational improvement thesis over passive capital.
- Aggregator-reported personal/early-stage profile (verify directly with him): seed through Series B, checks roughly $100K–$5.0M with a ~$1.5M sweet spot, focused on Retail/consumer and FinTech in the Boston/New England area (source: NFX Signal — not an official Bain Capital mandate).
- No publicly published first-person thesis statement was found; the above is synthesized from his firm bio and third-party investor databases.
Notable Investments
- Brakes Foodservice — UK/European foodservice wholesale distributor; Scherer held an interim executive role during Bain's involvement.
- ATW — Bain Capital portfolio company where Scherer served in an interim executive capacity.
- Nutanix — enterprise cloud / hyperconverged infrastructure company.
- Brillio — digital technology consulting and services firm.
- Cerevel Therapeutics — neuroscience biotech (a Bain Capital–backed company; later acquired by AbbVie).
- QuVa Pharma — outsourced sterile pharmaceutical compounding.
- Newlinks Technology — listed among associated portfolio names.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.